Chat with us
Research Assistance
Online
  • Please enter your first name.

Middle East & Africa Adme Toxicology Testing Market

The adme toxicology testing market in Middle East & Africa is expected to reach a projected revenue of US$ 347.6 million by 2030. A compound annual growth rate of 6.7% is expected of Middle East & Africa adme toxicology testing market from 2024 to 2030.

  • Biotechnology
    • Drug discovery & development
      • adme toxicology testing market
Revenue, 2024 (US$M)
$220.6
Forecast, 2030 (US$M)
$347.6
CAGR, 2025 - 2030
6.7%
Report Coverage
Middle East & Africa

Middle East Africa Adme Toxicology Testing Market, 2018-2030 (US$M)

Middle East Africa Adme Toxicology Testing Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the adme toxicology testing market

Every figure cited from GVR research

MEA adme toxicology testing market highlights

  • The MEA adme toxicology testing market generated a revenue of USD 220.6 million in 2023.
  • The market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
  • In terms of segment, cell culture tech was the largest revenue generating technology in 2023.
  • Cell Culture Tech is the most lucrative technology segment registering the fastest growth during the forecast period.


MEA data book summary

Market revenue in 2023USD 220.6 million
Market revenue in 2030USD 347.6 million
Growth rate6.7% (CAGR from 2023 to 2030)
Largest segmentCell culture tech
Fastest growing segmentCell Culture Tech
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCell Culture Tech
Key market players worldwideThermo Fisher Scientific Inc, Promega, Agilent Technologies Inc, Curia, Dassault Systemes SE, Beckman Coulter, Catalent Inc, Charles River Laboratories International Inc, Labcorp Drug Development, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Miltenyi Biotec, IQVIA Holdings Inc


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.3% of the global adme toxicology testing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,831.6 million by 2030.

The growing concerns for tropical diseases, such as malaria, tuberculosis and HIV/AIDS, is anticipated to spur the investment in drug development in the region. A number of pharmacokinetics and pharmacodynamics studies are being conducted in the region to evaluate the efficacy of a drug against disease like malaria, HIV, and other bacterial infections.

For instance, in July 2013, pharmacokinetics studies for efavirenz, a medicine developed for the treatment of HIV-AIDs, was carried out in two sub-Saharan Africa populations.

Similarly, in 2015, the pharmacokinetics of a multicomponent herbal preparation was conducted in healthy African and Chinese and volunteers. These studies are expected to positively influence the uptake of methods for ADME toxicity testing in the coming years.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Adme Toxicology Testing Market Companies

NameProfile# EmployeesHQWebsite
GE HealthCare Technologies Inc Common StockView profile 51,000500 West Monroe Street, Chicago, IL, United States, 60661www.gehealthcare.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Eurofins Scientific SEView profile 61,79823 Val Fleuri, Luxembourg, Luxembourg, L-1526www.eurofins.com
Charles River Laboratories International IncView profile 21,400251 Ballardvale Street, Wilmington, MA, United States, 01887www.criver.com
Catalent IncView profile 17,21914 Schoolhouse Road, Somerset, NJ, United States, 08873www.catalent.com
Miltenyi BiotecView profile 1001-5000Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europewww.miltenyibiotec.com
Labcorp Drug DevelopmentView profile 10001+Princeton, New Jersey, United States, North Americadrugdevelopment.labcorp.com
IQVIA Holdings IncView profile 87,0002400 Ellis Road, Durham, NC, United States, 27703www.iqvia.com
Beckman CoulterView profile 10001+Brea, California, United States, North Americawww.beckmancoulter.com

Middle East & Africa adme toxicology testing market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ADME Toxicology Testing Market will help companies and investors design strategic landscapes.


Cell Culture Tech was the largest segment with a revenue share of 100.0% in 2023.

Horizon Databook has segmented the Middle East & Africa adme toxicology testing market based on cell culture tech covering the revenue growth of each sub-segment from 2018 to 2030.




The growing concerns for tropical diseases, such as malaria, tuberculosis and HIV/AIDS, is anticipated to spur the investment in drug development in the region. A number of pharmacokinetics and pharmacodynamics studies are being conducted in the region to evaluate the efficacy of a drug against disease like malaria, HIV, and other bacterial infections.

For instance, in July 2013, pharmacokinetics studies for efavirenz, a medicine developed for the treatment of HIV-AIDs, was carried out in two sub-Saharan Africa populations.

Similarly, in 2015, the pharmacokinetics of a multicomponent herbal preparation was conducted in healthy African and Chinese and volunteers. These studies are expected to positively influence the uptake of methods for ADME toxicity testing in the coming years.

  • Middle East & Africa Adme Toxicology Testing Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Cell Culture Tech
    • High Throughput Tech
    • Molecular Imaging
    • OMICS Tech
  • Middle East & Africa Adme Toxicology Testing Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Systemic Toxicity
    • Renal Toxicity
    • Hepatotoxicity
    • Neurotoxicity
    • Others
  • Middle East & Africa Adme Toxicology Testing Market Method Outlook (Revenue, USD Million , 2018-2030)
    • Cellular Assay
    • Biochemical Assay
    • In Silica
    • Ex-vivo

Reasons to subscribe to adme toxicology testing market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of adme toxicology testing market databook

  • Our clientele includes a mix of adme toxicology testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa adme toxicology testing market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa adme toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Middle East Africa Adme Toxicology Testing Market, 2018-2030 (US$M)

No Access Stack Chart

MEA adme toxicology testing market statistics, by technology, 2018-2030 (US$M)

No Access Pie Chart

MEA adme toxicology testing market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more